Paige raises $100M series C funding USA
Paige is an NYX-based digital diagnostics company that raised $100M in series C funding. The company aims to use the funds so that it can accelerate the development of Al-based clinical applications, biomarkers as well as diagnostics along with moving ahead to invest in sales and marketing. It also has efforts to scale the product adoption by the hospitals as well as labs and build out its personal engineering and commercial teams which have plans to employ about 70 new employees in recent years. computational paige 100m series casdin capital has been founded in the year 2017 and since then Paige builds computational pathology products which are designed in a way that the patients and their care teams can make treatment decisions more informed. The products of the company have received FDA breakthrough designation and can deliver insights to pathologists and oncologists so that they can reach professionally more precise diagnoses for patients. We hope tha...